Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

21.05.24	Lilly Reports Positive Phase 3 Trial Results Of Mirikizumab In Crohn's Disease (RTTNews)
21.05.24	More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved clinical remission at one year, including patients with previous biologic failure (EN, Eli Lilly)
16.05.24	Lilly Says Phase 3 Trials Of Once-weekly Insulin In Type 2 Diabetes Meets Primary Endpoint (RTTNews)
16.05.24	With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin (EN, Eli Lilly)
15.05.24	Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer (EN, Eli Lilly)
14.05.24	Lilly Update on Mounjaro® and Zepbound® (tirzepatide) Compounding Litigation (EN, Eli Lilly)
07.05.24	FDA Advisory Committee To Convene Meeting To Discuss On Eli Lilly's Alzheimer's Drug (RTTNews)
07.05.24	Lilly Statement on FDA Advisory Committee Meeting on Donanemab for Early Symptomatic Alzheimer’s Disease (EN, Eli Lilly)
06.05.24	Lilly Declares Second-Quarter 2024 Dividend (EN, Eli Lilly)
30.04.24	Eli Lilly Boosts FY24 Outlook - Update (RTTNews)
30.04.24	Eli Lilly And Co. Q1 Profit Increases, beats estimates (RTTNews)
30.04.24	Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum (EN, Eli Lilly)
26.04.24	Lilly Recommends Shareholders Reject “Mini-Tender” Offer by Tutanota LLC (EN, Eli Lilly)
22.04.24	Lilly Acquires New Injectable Medicine Manufacturing Facility from Nexus Pharmaceuticals (EN, Eli Lilly)
17.04.24	Eli Lilly's Weight Loss Drug Zepbound Shows Promise In Reducing Sleep Apnea (RTTNews)
17.04.24	Lilly's Tirzepatide To Treat Sleep Apnea Meets Primary Goals In Late-stage Studies (RTTNews)
17.04.24	Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity (EN, Eli Lilly)
16.04.24	Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement (EN, Eli Lilly)
11.04.24	Roche's Elecsys PTau217 Blood Test Receives FDA Breakthrough Designation For Alzheimer's Detection (RTTNews)
06.04.24	Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance® (empagliflozin) on risk of heart failure hospitalization and death in adults following a heart attack (EN, Eli Lilly)
13.03.24	Eli Lilly Strikes Deal With Amazon Pharmacy To Deliver Prescription Drugs (RTTNews)
11.03.24	Eli Lilly Stock Drops 4% (RTTNews)
11.03.24	Lilly: Majority Of People With AD & Skin Of Color Experienced Skin Improvement In Lebrikizumab Study (RTTNews)
10.03.24	More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab study (EN, Eli Lilly)
08.03.24	FDA Delays Decision On Lilly's Alzheimer's Drug (RTTNews)
08.03.24	U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of Donanemab (EN, Eli Lilly)
07.03.24	Open Letter Regarding the Use of Mounjaro® (tirzepatide) and Zepbound® (tirzepatide) (EN, Eli Lilly)
07.03.24	Lilly's Newest Phase of Get Better Campaign Challenges Misperceptions About Obesity Care (EN, Eli Lilly)
05.03.24	Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting (EN, Eli Lilly)
21.02.24	Jazz Pharma Names Eli Lilly's Philip Johnson CFO, Effective March 1 (RTTNews)
20.02.24	Lilly to Participate in Cowen's 44th Annual Health Care Conference (EN, Eli Lilly)
09.02.24	Philip Johnson to Retire as Lilly Treasurer (EN, Eli Lilly)
06.02.24	Eli Lilly Q4 Results Top Estimates (RTTNews)
06.02.24	Eli Lilly Guides FY24 Revenues Above Estimates - Update (RTTNews)
06.02.24	Eli Lilly And Co. Q4 Profit Increases, beats estimates (RTTNews)
06.02.24	Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance (EN, Eli Lilly)
30.01.24	HUTCHMED Announces Marketing Approval For ELUNATE By Pharmacy And Poisons Board Of Hong Kong (RTTNews)
25.01.24	Johna Norton to Retire as Lilly Executive Vice President of Global Quality (EN, Eli Lilly)
23.01.24	Positive Phase 1/2 Clinical Trial Data for an Investigational Gene Therapy for Genetic Hearing Loss to be Presented at the Association for Research in Otolaryngology 2024 MidWinter Meeting (EN, Eli Lilly)
23.01.24	Lilly Confirms Date and Conference Call for Fourth-Quarter 2023 Financial Results and 2024 Financial Guidance (EN, Eli Lilly)
04.01.24	Eli Lilly Launches LillyDirect To Help Patients Manage Health, Access Medicines (RTTNews)
04.01.24	Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect™ (EN, Eli Lilly)
04.01.24	Open Letter Regarding the Use of Mounjaro® (tirzepatide) and Zepbound™ (tirzepatide) (EN, Eli Lilly)
02.01.24	Lilly to Participate in J.P. Morgan Healthcare Conference (PR Newswire)
02.01.24	Lilly to Participate in J.P. Morgan Healthcare Conference (EN, Eli Lilly)
28.12.23	Innovent Biologics, Xuanzhu Collaborate On Clinical Trial For Advanced Solid Tumors In China (RTTNews)
27.12.23	Lilly Acquires Point Biopharma For Approx. $1.4 Bln (RTTNews)
27.12.23	Lilly Completes Acquisition of POINT Biopharma (PR Newswire)
18.12.23	Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 22, 2023 (PR Newswire)
12.12.23	Updated Data from the BRUIN Phase 1/2 Study of Pirtobrutinib in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Presented at the 2023 ASH Annual Meeting (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

29.12.24		Novartis-Aktie: Novartis muss sich erneut Schmiergeld-Vorwürfen stellen
27.12.24		Anleger in New York halten sich zurück: Dow Jones beendet die Freitagssitzung im Minus
27.12.24		BioNTech und Pfizer zahlen Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester
27.12.24		Börse Frankfurt: DAX zum Handelsende auf grünem Terrain
27.12.24		Freitagshandel in Frankfurt: LUS-DAX zeigt sich letztendlich fester
27.12.24		Optimismus in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen
27.12.24		Börse Europa: Euro STOXX 50 verbucht zum Ende des Freitagshandels Zuschläge
27.12.24		SLI-Handel aktuell: Zum Handelsende Gewinne im SLI

29.12.24

Novartis-Aktie: Novartis muss sich erneut Schmiergeld-Vorwürfen stellen

27.12.24

Anleger in New York halten sich zurück: Dow Jones beendet die Freitagssitzung im Minus

27.12.24

BioNTech und Pfizer zahlen Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester

27.12.24

Börse Frankfurt: DAX zum Handelsende auf grünem Terrain

27.12.24

Freitagshandel in Frankfurt: LUS-DAX zeigt sich letztendlich fester

27.12.24

Optimismus in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

27.12.24

Börse Europa: Euro STOXX 50 verbucht zum Ende des Freitagshandels Zuschläge

27.12.24

SLI-Handel aktuell: Zum Handelsende Gewinne im SLI

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Eli Lilly

Aktien Top/Flop

Eli Lilly Peer Group Nachrichten

Meistgelesene Nachrichten